We found that phenformin significantly inhibits proliferation, migration, invasion, and EMT in ErbB2-overexpressing breast cancer cells and blocks tumor growth in a syngeneic mammary tumor model, which were associated with the inhibition of IGF1R stimulation. The gene discussed is ERBB2; the disease is neoplasm.